Investing Profile

Daniel Coley

VCInvestor
Investing in B2B software in the Southeast US
Photo of Daniel Coley, Investor at Cofounders Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Babson College Network
30 CONNECTIONS
$250K - $2.0M
$1M
14
CompanyStageDateRound SizeTotal Raised
TEDU
SeedAug 2024$2M
$2M
Ecomap
Seed-2Aug 2023$3.5
$3.5
Mercy BioAnalytics
Series AApr 2023$41M
$41M
Alpheus Medical
Series ANov 2022$14M
$30M
Co-investors: Klaus Veitinger (OrbiMed), Imran Eba (Action Potential Venture Capital)
Naveris
Series ASep 2022$33M
$33M
Auron Therapeutics
Series AJul 2022$48M
$48M
Co-investors: Eric Shiozaki (DCVC (Data Collective)), Alexandra Cantley (Polaris Partners), Marianne Mertens (Apollo Health Ventures)
Lunit
Pre-IPO RoundNov 2021$26M
$87M
Co-investors: Garheng Kong (HealthQuest Capital)
Immunitas Therapeutics
Series BAug 2021$58M
$97M
Co-investors: Geeta Vemuri (Agent Capital), Laura Brass (Novartis Venture Fund), Lucio Iannone (Leaps by Bayer), Brian Halak (Domain Associates), Christoph Westphal (Longwood Fund)
B2B Software and SaaS
Crypto or biotech or cyber security
Associate BrightEdge (American Cancer Society Impact Fund)2019 - 2023
Analyst SunTrust Robinson Humphrey2018 - 2019
Babson College B.S.